Abbott Diabetes And Cardiology Updates Test Growth Story For Investors [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Laboratories (NYSE:ABT) reported new FreeDM2 trial results on its FreeStyle Libre continuous glucose monitoring system for people with Type 2 diabetes using basal insulin. The company also introduced its next generation XIENCE Skypoint drug eluting stent in India, expanding its interventional cardiology offering. These developments highlight fresh clinical data in diabetes care and a broader global rollout of Abbott's cardiovascular technologies. At a share price of $109.95, Abbott Laboratories sits in the middle of ongoing product and clinical news that keeps the focus on its role across diabetes care and cardiology devices. The stock has seen a 19.2% return over 3 years, while returns over 1 year and year to date show declines of 12.2% and 11.5% respectively, giving investors mixed recent share performance alongside longer term gains. For investors tracking NYSE:ABT, the combination of fresh trial data in diabetes and a new stent launch in a large market like India a
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip? [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India [Yahoo! Finance]Yahoo! Finance
- Invesco Rising Dividends Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- How The Story On Abbott Laboratories (ABT) Is Shifting As Analysts Rework Targets And Risks [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/13/26 - Form ARS
- 3/13/26 - Form DEF
- 3/13/26 - Form DEFA14A
- ABT's page on the SEC website